摘要
目的探讨超声联合数字钼靶X线对不同级别乳腺导管原位癌(DCIS)的应用价值。方法经病理学证实的48例女性乳腺导管原位癌,均采用彩色多普勒超声检查和钼靶X线检查对不同级别导管原位癌进行诊断与鉴别诊断。结果钼靶对低、中、高级别导管原位癌诊断为BI-RADS4或5级(中度或高度怀疑恶性病变)分别为7例、8例、20例;彩色多普勒超声对低、中、高级别导管原位癌诊断为BI-RADS4或5级分别为8例、9例、17例;同时两种方法联合对低、中、高级别导管原位癌诊断为BI-RADS4或5级分别为9例、10例、21例。结论彩色多普勒超声与钼靶X线摄影联合应用可提高对不同级别导管原位癌诊断率,值得临床推广。
Objective To investigate the ultrasound combined with digital mammography X-ray of different grade Ductal carcinoma in situ (Ductal carcinoma in situ, DCIS) application value. Method Confirmed by pathology of 48 cases of female breast ductal carcinoma in situ, all use of Color doppler ultrasound and molybdenum target X-ray on different levels for diagnosis and differential diagnosis of ductal carcinoma in situ. Results Mammography for low, medium and high grade ductal carcinoma in situ diagnosis of BI - RADS4 or level 5 (moderately or highly suspected malignant lesions) of 7 cases respectively, 8 cases, 20 cases; color doppler flow imaging (cdfi) in low, medium and high grade ductal carcinoma in situ diagnosis of BI - RADS4 or level 5 of 8 cases, 9 cases, 17 cases respectively; the combination of the two methods at the same time low, medium and high grade ductal carcinoma in situ diagnosis of BI - RADS4 or level 5 of 9 cases, 10 cases, 21 cases respectively. Conclusion Color doppler ultrasonography and molybdenum target X-ray photography combined use of ductal carcinoma in situ with different grades can be improved diagnostic rate, worthy of clinical promotion.
出处
《中国医药指南》
2013年第23期1-1,3,共2页
Guide of China Medicine
基金
广东省中山市卫生局立项课题(编号:J2012117)
关键词
乳腺导管原位癌
超声
钼靶X线
Breast ductal carcinoma in sit'u
Ultrasound
Line of molybdenum target X